Table 1. All attributes in PMI3 groups (PMI:non-PMI =1:1 from 10,886).
| Categories | Variables | Drop | Mean | |||||
|---|---|---|---|---|---|---|---|---|
| PMI group (N=2,274) | Non-PMI group (N=2,274) | P | PMI group (N=2,274) | Non-PMI group (N=2,274) | P | |||
| General information | Gender, male | 67% | 69% | 0.203 | 69% | 75% | <0.05 | |
| Age, years | 64.51±18.3 | 62.45±21.32 | <0.05 | 67.85±10.05 | 67.71±9.88 | 0.311 | ||
| BMI, kg/m2 | 23.44±10.81 | 23.98±6.11 | <0.05 | 24.54±9.52 | 24.7±4.4 | 0.258 | ||
| SYB, mmHg | 133.9±22.95 | 133.1±35.13 | 0.361 | 134.78±20.19 | 134.03±33.3 | 0.493 | ||
| DBP, mmHg | 73.29±21.69 | 73.72±18.64 | 0.480 | 73.87±20.68 | 74.26±17.51 | 0.945 | ||
| UAP, yes | 44% | 40% | <0.05 | 44% | 40% | <0.05 | ||
| Medical history | Hyper, yes | 71% | 64% | <0.05 | 73% | 69% | <0.05 | |
| DM, yes | 27% | 24% | <0.05 | 27% | 24% | <0.05 | ||
| P-CVD, yes | 23% | 19% | <0.05 | 23% | 19% | <0.05 | ||
| P-PCI, yes | 25% | 33% | <0.05 | 25% | 33% | <0.05 | ||
| Smoking, yes | 39% | 42% | <0.05 | 39% | 42% | 0.076 | ||
| Drinking, yes | 24% | 29% | <0.05 | 24% | 29% | <0.05 | ||
| F-CVD, yes | 13% | 13% | 0.756 | 13% | 13% | 0.534 | ||
| Biochemistry results | TC, mmol/L | 3.79±1.26 | 3.8±1.34 | 0.780 | 3.89±1.08 | 3.95±1.1 | 0.363 | |
| HDL-C, mmol/L | 0.99±0.31 | 1.01±0.34 | 0.141 | 1.02±0.27 | 1.05±0.28 | 0.223 | ||
| LDL-C, mmol/L | 1.96±0.9 | 1.88±0.92 | <0.05 | 2.02±0.84 | 1.96±0.84 | <0.05 | ||
| VLDL-C, mmol/L | 0.89±1.31 | 0.94±1.17 | 0.259 | 0.92±1.3 | 0.97±1.15 | 0.204 | ||
| TG, mmol/L | 1.54±1.02 | 1.53±1.03 | 0.686 | 1.59±0.98 | 1.59±0.98 | 0.375 | ||
| LPa, mg/dL | 25.16±26.64 | 21.55±24.18 | <0.05 | 25.86±26.29 | 22.56±23.76 | <0.05 | ||
| TB, µmol/L | 12.58±6.33 | 13.0±6.78 | <0.05 | 12.82±6.09 | 13.42±6.36 | 0.886 | ||
| UB, µmol/L | 8.88±4.87 | 9.02±4.85 | 0.324 | 9.06±4.71 | 9.33±4.55 | 0.628 | ||
| CB, µmol/L | 3.7±2.05 | 3.97±2.87 | <0.05 | 3.77±1.98 | 4.09±2.78 | 0.597 | ||
| UA, µmol/L | 349.19±120.86 | 339.46±115.32 | <0.05 | 363.06±97.65 | 354.85±89.15 | <0.05 | ||
| Cr, µmol/L | 81.92±38.55 | 82.91±48.83 | 0.446 | 81.95±38.51 | 82.98±48.76 | 0.545 | ||
| BUN, mmol/L | 5.41±2.14 | 5.2±1.89 | <0.05 | 5.42±2.14 | 5.21±1.88 | <0.05 | ||
| eGFR, mL/min | 76.84±24.57 | 75.2±26.87 | <0.05 | 80.2±18.53 | 80.85±17.06 | <0.05 | ||
| Blood routine examinations | WBC, ×109 | 6.57±2.05 | 6.41±1.68 | <0.05 | 6.57±2.05 | 6.42±1.67 | <0.05 | |
| Lymphocyte, % | 24.69±7.83 | 25.58±8.05 | <0.05 | 24.69±7.83 | 25.58±8.05 | 0.357 | ||
| Neutrophil, % | 64.03±9.83 | 62.15±11.32 | <0.05 | 64.03±9.83 | 62.15±11.32 | 0.202 | ||
| Plt, ×109 | 176.82±57.13 | 173.45±55.71 | <0.05 | 177.29±56.4 | 173.92±54.99 | 0.075 | ||
| MPV, fL | 9.15±1.39 | 9.04±1.43 | <0.05 | 9.15±1.38 | 9.06±1.38 | 0.951 | ||
| CRP, mg/L | 4.36±10.5 | 3.06±8.99 | <0.05 | 4.65±10.43 | 3.97±8.81 | <0.05 | ||
| CKMB, IU | 17.63±12.77 | 13.0±9.64 | <0.05 | 17.63±12.77 | 13.0±9.64 | <0.05 | ||
| FBG, mg/L | 6.57±2.51 | 6.6±2.4 | 0.638 | 6.57±2.51 | 6.61±2.39 | 0.668 | ||
| Medicine | anti-Hyper Med, yes | 85% | 83% | <0.05 | 85% | 83% | <0.05 | |
| Statins, yes | 98% | 98% | 0.674 | 98% | 98% | 0.394 | ||
| anti-Plt Med, yes | 100% | 100% | <0.05 | 100% | 100% | <0.05 | ||
| Trimetazidine, yes | 25% | 20% | <0.05 | 25% | 20% | <0.05 | ||
| Fibrates, yes | 0% | 0% | 0.466 | 0% | 0% | 0.145 | ||
| Cilostazol, yes | 2% | 1% | <0.05 | 2% | 1% | <0.05 | ||
| Warfarin, yes | 1% | 1% | 0.857 | 1% | 1% | 0.719 | ||
| PPI, yes | 49% | 38% | <0.05 | 49% | 38% | <0.05 | ||
| Ezetimibe, years | 8% | 5% | <0.05 | 8% | 5% | <0.05 | ||
| Procedure factors | FFR, IVUS, OCT, yes | 13% | 8% | <0.05 | 13% | 8% | <0.05 | |
| CTO, yes | 11% | 6% | <0.05 | 11% | 6% | <0.05 | ||
| ACC/AHA TypeB2C, yes | 39% | 18% | <0.05 | 39% | 18% | <0.05 | ||
| Left coronary artery, yes | 26% | 30% | <0.05 | 26% | 30% | <0.05 | ||
| Total length of stents, mm | 49.66±24.92 | 33.16±20.15 | <0.05 | 49.66±24.92 | 33.16±20.15 | <0.05 | ||
| Number of stents, N | 1.71±0.83 | 1.39±0.67 | <0.05 | 1.71±0.83 | 1.39±0.67 | <0.05 | ||
| Diameter of stent ≥2.5 mm | 90 | 93 | <0.05 | 90 | 93 | <0.05 | ||
| Calcification, yes | 16% | 7% | <0.05 | 16% | 7% | <0.05 | ||
| PCI without dilation, yes | 11% | 13% | 0.072 | 11% | 13% | <0.05 | ||
P value: t-statistic testing between negative group and positive group, <0.05 means significant statistically. BMI, body mass index; SYB, systolic blood pressure; DBP, diastolic blood pressure; UAP, unstable angina pectoris; Hyper, hypertension; DM, diabetes mellitus; P-CVD, past history of cerebral-or-cardiovascular diseases; P-PCI, past history of percutaneous coronary intervention; F-CVD, family history of cerebral-or-cardiovascular diseases; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipid cholesterol; VLDL-C, very low density lipid cholesterol; TG, triglyceride; LPa, lipid protein alpha; TB, total bilirubin; UB, unconjugated bilirubin; CB, conjugated bilirubin; UA, uric acid; Cr, creatinine; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; WBC, white blood cells; Plt, platelet; MPV, mean platelet volume; CRP, C-reactive protein; CKMB, Creatine Kinase MB; FBG, fibrinogen; anti-Hyper Med, anti-hypertension medicine; anti-Plt Med, anti-platelet medicine; PPI, proton-pump inhibitors; FFR, fractional flow reserve; IVUS, intravascular ultrasound; OCT, optical coherence tomography; CTO, chronic total occlusions.